홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Bromide → 7,8-Dihydro-5H-pyrido[3,2-b]azepine-6,9-dione 9-[(3,5-dichlorophenyl)hydrazone]

HRID 2425861
인쇄

반응식

HRID 2425861 반응식
[N:1]1[C:11]2[C:10](=O)[CH2:9][CH2:8][C:7](=[O:13])[NH:6][C:5]=2[CH:4]=[CH:3][CH:2]=1.Cl.[Cl:15][C:16]1[CH:17]=[C:18]([NH:23][NH2:24])[CH:19]=[C:20]([Cl:22])[CH:21]=1.C([O-])(=O)C.[Na+].[K+].[Br-]>>[Cl:15][C:16]1[CH:17]=[C:18]([NH:23][N:24]=[C:10]2[CH2:9][CH2:8][C:7](=[O:13])[NH:6][C:5]3[CH:4]=[CH:3][CH:2]=[N:1][C:11]2=3)[CH:19]=[C:20]([Cl:22])[CH:21]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 4

HCID 253877Potassium BromideHCID 517045Sodium AcetateHCID 2723913(3,5-Dichlorophenyl)hydrazine monohydrochlorideHCID 457893917,8-Dihydro-5H-pyrido[3,2-B]azepine-6,9-dione

생성물 1

HCID 1363439297,8-Dihydro-5H-pyrido[3,2-b]azepine-6,9-dione 9-[(3,5-dichlorophenyl)hydrazone]

실험 절차

Prepared according to general procedure A from 338.5 mg (1.92 mmol) 5H-pyrido[3,2-b]azepine-6,9(7H,8H)-dione, 452 mg (2.11 mmol) (3,5-dichlorophenyl)hydrazine hydrochloride, and 169 mg (2.11 mmol) sodium acetate. Recrystallization from ethanol afforded a beige powder. Yield: 213 mg (33%); m.p. 270° C. (dec.); IR (KBr): 3281 cm−1 (NH), 3067/3029 cm−1 (CH-arom.), 2892 cm−1 (CH-aliph.), 1671 cm−1 (C═O); 1H-NMR (DMSO-d6, 400 MHz): δ (ppm)=2.57-2.60 (m, 2H, azepine-CH2, part of AA′XX′-system), 3.02-3.05 (m, 2H, azepine-CH2, part of AA′XX′-system), 6.91-6.92 (m, 1H, arom. H), 7.16 (d, 2H, 1.9 Hz, arom. H), 7.37-7.44 (m, 2H, arom. H), 8.44 (dd, 1H, 4.2/1.8 Hz, arom. H), 9.72 (s, 1H, NH), 9.81 (s, 1H, NH); C15H12Cl2N4O (335.20).

후처리

  1. customPrepared
  2. customRecrystallization from ethanol
  3. customafforded a beige powder

출처 및 근거

ORD 기록
ord-7a8a7b43bc234a209a7dbda614770635
출처 데이터셋
uspto-grants-2011_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07968535B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트